From:  A brief approach to hypertension in type 2 diabetes mellitus

Target BP levels and preference of drugs in diabetic patients in several guidelines

GuidelinesHypertensionTarget BPPreference of drugs
ACC/AHA 2017140/90 mmHg< 130/80 mmHgNo preference
HCGC 2020130/80 mmHg< 130/80 mmHgA (if not satisfactory A + D)
ISH 2020140/90 mmHg< 130/80 mmHg (< 140/80 mmHg in elderly)A + C (C + D for blacks)
ESH 2023140/90 mmHg< 130/80 mmHgA + C or D
ESC 2024140/90 mmHg< 130/80 mmHgA + C or D
ADA 2025130/80 mmHg< 130/80 mmHg< 150/90 mmHg: A or C or D; A (if albuminuria or CAD)
> 150/90 mmHg: two of A or C or D; A + C or D (if albuminuria or CAD)
Return to article view

β-blockers are recommended in the presence of compelling indications like left ventricular dysfunction, coronary artery disease (CAD), or tachycardia. ACC: American College of Cardiology; ADA: American Diabetes Association; AHA: American Heart Association; BP: blood pressure; ESC: European Society of Cardiology; ESH: European Society of Hypertension; HCGC: Hypertension Canada Guidelines Committee; ISH: International Society of Hypertension. A: angiotensin-converting enzyme inhibitor/angiotensin receptor blockers; C: dihydropyridine calcium-channel blockers; D: diuretics